Navidea Biopharmaceuticals, Inc. (NAVB)
Q1 2020 Results Earnings Conference Call
May 14, 2020, 5:00 pm ET
Company Participants
Jed Latkin - Chief Executive Officer, Chief Financial Officer, Chief Operating Officer
Mike Rosol - Chief Medical Officer
Erika Eves - Director of Finance and Administration
Conference Call Participants
Michael Okunewitch - Maxim Group
Joe Pellicane - Private Investor
Mike Rigali - Private Investor
Presentation
Operator
Greeting and welcome to the Navidea Biopharmaceuticals quarter one 2020 earnings conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.